Trials / Completed
CompletedNCT02263066
Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFⅧ Contained Regular Prophylaxis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 181 (actual)
- Sponsor
- Bayer · Industry
- Sex
- Male
- Age
- 2 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
To assess and describe real-life treatment choices for rFⅧ contained regular prophylaxis/bleeding prevention treatment in pediatric hemophilia patients in China (2007-2013)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | BAY14-2222_Kogenate-FS FVIII | Depends on Doctor's decision |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2014-10-13
- Last updated
- 2015-07-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02263066. Inclusion in this directory is not an endorsement.